Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Country / region: France Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20152
20161
20171
20182
20193
20211
20222
20234
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Active, not recruiting7
Terminated6
Completed2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alentis Therapeutics AG2
Amgen2
Merus B.V.2
Centre Antoine Lacassagne1
Daiichi Sankyo1
Eli Lilly and Company1
GERCOR - Multidisciplinary Oncology Cooperative Group1
Genmab1
Gilead Sciences1
Grey Wolf Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck24
Colorectal Neoplasms6
Head and Neck Neoplasms5
Stomach Neoplasms5
Uterine Cervical Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Melanoma4
Esophageal Neoplasms3
Triple Negative Breast Neoplasms3
Biliary Tract Neoplasms2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.